Related Experiment Video
Updated: Aug 1, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex
Sihui Cai1,2, Chenqiu Zhang1,2, Zhen Zhuang3
1Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, The First Affiliated Hospital of Sun Yat-sen University, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China.
Abstract:
Currently, the incidence and fatality rate of SARS-CoV-2 remain continually high worldwide. COVID-19 patients infected with SARS-CoV-2 exhibited decreased type I interferon (IFN-I) signal, along with limited activation of antiviral immune responses as well as enhanced viral infectivity. Dramatic progresses have been made in revealing the multiple strategies employed by SARS-CoV-2 in impairing canonical RNA sensing pathways. However, it remains to be determined about the SARS-CoV-2 antagonism of cGAS-mediated activation of IFN responses during infection. In the current study, we figure out that SARS-CoV-2 infection leads to the accumulation of released mitochondria DNA (mtDNA), which in turn triggers cGAS to activate IFN-I signaling. As countermeasures, SARS-CoV-2 nucleocapsid (N) protein restricts the DNA recognition capacity of cGAS to impair cGAS-induced IFN-I signaling. Mechanically, N protein disrupts the assembly of cGAS with its co-factor G3BP1 by undergoing DNA-induced liquid-liquid phase separation (LLPS), subsequently impairs the double-strand DNA (dsDNA) detection ability of cGAS. Taken together, our findings unravel a novel antagonistic strategy by which SARS-CoV-2 reduces DNA-triggered IFN-I pathway through interfering with cGAS-DNA phase separation.
Insights
SARS-CoV-2 hinders the body's antiviral defenses by blocking the cGAS-STING pathway. The virus's nucleocapsid protein prevents DNA sensing, thus reducing type I interferon signaling crucial for fighting infection.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- SARS-CoV-2 infection is associated with suppressed type I interferon (IFN-I) signaling, impairing antiviral responses.
- While SARS-CoV-2 strategies against RNA sensing are known, its antagonism of DNA sensing pathways like cGAS remains unclear.
Purpose of the Study:
- To investigate the antagonism of cGAS-mediated IFN-I responses by SARS-CoV-2 during infection.
- To elucidate the molecular mechanisms by which SARS-CoV-2 interferes with DNA sensing pathways.
Main Methods:
- Studied the impact of SARS-CoV-2 infection on mitochondrial DNA (mtDNA) release and cGAS activation.
- Investigated the role of SARS-CoV-2 nucleocapsid (N) protein in inhibiting cGAS-DNA binding and IFN-I signaling.
- Utilized liquid-liquid phase separation (LLPS) assays to analyze the interaction between N protein, cGAS, and dsDNA.
Main Results:
- SARS-CoV-2 infection causes accumulation of released mtDNA, which normally activates cGAS and IFN-I signaling.
- The SARS-CoV-2 N protein inhibits cGAS-mediated IFN-I signaling by disrupting cGAS-DNA recognition.
- N protein interferes with cGAS-G3BP1 co-factor assembly via DNA-induced LLPS, impairing dsDNA detection.
Conclusions:
- SARS-CoV-2 employs a novel antagonistic strategy to evade innate immunity by disrupting cGAS-DNA phase separation.
- This mechanism effectively impairs the DNA-triggered IFN-I pathway, contributing to viral infectivity and pathogenesis.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
Leaky Scanning
Single Nucleotide Polymorphisms-SNPs
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

